The latest quarterly R&D expense is $18.91 Million with a QoQ Growth of +5.91%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $18.91M.
$18.91M
$18.91 Million
Q2 FY2026 · 2026-06-30
+5.91%
vs. $17.85M prior quarter
20
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $18.91M | +5.91% | +0.61% |
| Q1 FY2026Period end 2026-03-31 | $17.85M | +7.32% | +6.99% |
| Q4 FY2025Period end 2025-12-31 | $16.63M | -6.15% | +28.43% |
| Q3 FY2025Period end 2025-09-30 | $17.72M | -5.68% | +15.55% |
| Q2 FY2025Period end 2025-06-30 | $18.79M | +12.62% | +2.26% |
| Q1 FY2025Period end 2025-03-31 | $16.69M | +28.83% | +38.66% |
| Q4 FY2024Period end 2024-12-31 | $12.95M | -15.56% | +35.82% |
| Q3 FY2024Period end 2024-09-30 | $15.34M | -16.53% | +58.29% |
| Q2 FY2024Period end 2024-06-30 | $18.38M | +52.70% | +165.50% |
| Q1 FY2024Period end 2024-03-31 | $12.03M | +26.19% | +79.20% |
| Q4 FY2023Period end 2023-12-31 | $9.54M | -1.59% | +28.01% |
| Q3 FY2023Period end 2023-09-30 | $9.69M | +40.02% | +108.43% |
| Q2 FY2023Period end 2023-06-30 | $6.92M | +3.07% | -1.25% |
| Q1 FY2023Period end 2023-03-31 | $6.72M | -9.86% | +15.44% |
| Q4 FY2022Period end 2022-12-31 | $7.45M | +60.23% | +92.59% |
| Q3 FY2022Period end 2022-09-30 | $4.65M | -33.67% | +143.91% |
| Q2 FY2022Period end 2022-06-30 | $7.01M | +20.49% | N/A |
| Q1 FY2022Period end 2022-03-31 | $5.82M | +50.39% | N/A |
| Q4 FY2021Period end 2021-12-31 | $3.87M | +102.92% | N/A |
| Q3 FY2021Period end 2021-09-30 | $1.91M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
